If pharmaceutical drug patents are an hourglass turned over on the day of approval - with the approaching loss of exclusivity ...

When President Donald Trump declared in May that he wanted drug companies to voluntarily cut their prices, few pharmaceutical ...

The Trump administration on Friday announced deals with nine drugmakers aimed at lowering pharmaceutical prices, bringing its total number of drug-pricing agreements to 14.

A handful of drugmakers have already disclosed pricing deals with the Trump administration and plan to sell certain drugs at a discount on TrumpRx, the White House's new direct-to-consumer website ...

We recently published 12 Stocks on Jim Cramer’s Radar. Pfizer Inc. (NYSE:PFE) is one of the stocks on Jim Cramer’s radar.

Pfizer is targeting supply chain emissions and engaging suppliers to build a climate-resilient value chain for the future ...

Find insight on Corcept Therapeutics, vaccine skepticism and more in the latest Market Talks covering the health care sector.

I agree to the Terms of Use , Privacy Notice and Cookie Notice. I agree to the Terms of Use , Privacy Notice and Cookie ...

Pfizer signaled Tuesday it expects a challenging 2026 as it invests in new products to offset declines in Covid-19 revenues ...

Pfizer Inc. forecast little to no sales growth next year as the drugmaker undertakes an effort to refresh its pipeline of hit ...

Pfizer on Tuesday forecast 2026 profit below Wall Street estimates as it expects a steep drop in sales of its COVID products ...